Holen Sie sich die Stockscreener-App
11.50
1.87%
0.1862
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrodinger (NASDAQ:SDGR) EVP Sells $10,708.80 in Stock - MarketBeat
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - marketscreener.com
Press Release: Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - 富途牛牛
Schrodinger stock hits 52-week low at 12.8 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Insider Sells $16,617.30 in Stock - MarketBeat
Schrodinger (NASDAQ:SDGR) Reaches New 12-Month LowWhat's Next? - MarketBeat
Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25 - pharmiweb.com
Schrodinger stock hits 52-week low at 12.8 USD - Investing.com
Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Trading Systems Reacting to (SDGR) Volatility - Stock Traders Daily
With A 26% Price Drop For Schrödinger, Inc. (NASDAQ:SDGR) You'll Still Get What You Pay For - simplywall.st
Schrodinger stock hits 52-week low at 13.43 USD By Investing.com - Investing.com Nigeria
Schrodinger (NASDAQ:SDGR) Hits New 12-Month LowShould You Sell? - MarketBeat
Schrodinger stock hits 52-week low at 13.43 USD - Investing.com
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 77.43% Potential Upside Amidst Innovative Drug Discovery and Software Growth - DirectorsTalk Interviews
TruBridge (TBRG) Surges 5.6%: Is This an Indication of Further Gains? - Nasdaq
Analysts Are Bullish on Top Healthcare Stocks: Spectral AI (MDAI), Schrodinger (SDGR) - The Globe and Mail
Schrodinger (NASDAQ:SDGR) Upgraded at Wall Street Zen - MarketBeat
Is Schrödinger Inc. stock a good dividend stock2025 Historical Comparison & Weekly Stock Performance Updates - mfd.ru
Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Schrodinger Inc stock hits 52-week low at $15.97 By Investing.com - Investing.com Nigeria
Schrodinger Inc stock hits 52-week low at $15.97 - Investing.com
How Schrodinger Inc. (SDGR) Affects Rotational Strategy Timing - Stock Traders Daily
Massachusetts Financial Services Co. MA Acquires 577,899 Shares of Schrodinger, Inc. $SDGR - MarketBeat
86,319 Shares in Schrodinger, Inc. $SDGR Acquired by Campbell & CO Investment Adviser LLC - MarketBeat
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
Schrodinger (NASDAQ:SDGR) Shares Down 5.2%Time to Sell? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $91.37 Million Stock Holdings in Schrodinger, Inc. $SDGR - MarketBeat
(SDGR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Schrödinger Inc. stock could be next big winnerMarket Performance Report & Low Risk Entry Point Guides - Bộ Nội Vụ
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities By Investing.com - Investing.com South Africa
Assessing Schrödinger (SDGR) Valuation After Recent Uneven Share Price Momentum - Yahoo Finance
Schrödinger partners with Lilly TuneLab on AI drug discovery - Drug Target Review
Schrodinger stock rating reiterated at Buy by TD Cowen on strategic priorities - Investing.com Australia
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities - BioSpace
Schrödinger outlines 2026 priorities after strong 2025 By Investing.com - Investing.com Nigeria
Schrödinger outlines 2026 priorities after strong 2025 - Investing.com
Manas AI Secures Strategic Advantage through Unique Deep Integration with Schrödinger’s Physics + AI Discovery Platform - 01net
Schrodinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Chemoinformatics Market to Reach US$ 24.43 Billion by 2033 | CAGR - openPR.com
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software - WKZO
Will Schrödinger Inc. stock benefit from automation2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Schrodinger (NASDAQ:SDGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat
Schrödinger partners with Lilly TuneLab to enhance drug discovery By Investing.com - Investing.com Nigeria
Schrödinger, Inc.'s (NASDAQ:SDGR) Earnings Haven't Escaped The Attention Of Investors - 富途牛牛
Is Schrödinger’s TuneLab AI Integration Reshaping the Investment Case For SDGR? - simplywall.st
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign - pharmiweb.com
Schrödinger (SDGR) Partners with Eli Lilly for AI-Driven Drug Di - GuruFocus
Schrodinger to offer Eli Lilly's AI drug discovery platform on its software - Reuters
7.07%
11.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):